COVID-19: Preventive measures in MS patients and others on immunomodulators
 

People with MS are advised not to interrupt their immunomodulating drug treatments on account of the COVID-19 pandemic--according to Dr. Robert Fox, one of the leading authorities on MS, who is affiliated with the Cleveland Clinic Neurological Institute and the Mellen Center for MS:

COVID-19: Preventive Measures in Multiple Sclerosis Patients and Others on Immuno-Modulators

I had posted another link here but it did not print. So I'll post this one and maybe it will post.

Get information on your risk of contracting the coronavirus while living with Mutltiple sclerosis | National MS Society | National Multiple Sclerosis Society

The National MS Society has been putting out helpful information about the coronavirus. They seem to be trying harder to be less of an exclusive club--meant mainly for people with MS who happen to be well off--to being an organization serving all kinds of people with MS, rich and poor.

There was a time years ago when they didn't do much but run fund-raising events and have support group meetings here and there, spottily.

In Chicago, for instance, they had hardly any support groups in the city itself. They were all out in the suburbs.

It was as if people in the city just didn't get MS, but that wasn't so.

Yes my university sent an info letter recommending that considered risk people against covid-19 should avoid going to the campus.

Considered vulnerable groups are:

• people with diabetes,
• cardiovascular disease (including hypertension),
• chronic lung disease,
• immunodeficiency,
• cancer under active treatment,
• pregnancy
• over 60 years
• chronic renal insufficiency,
• severe chronic liver disease,
• obesity (BMI> 40)